External Beam Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
Condition: Oligometastatic Prostate Cancer Interventions: Radiation: Hypofractionated external beam radiotherapy; Radiation: High dose rate brachytherapy; Radiation: Permanent seed implant; Radiation: Stereotactic body radiotherapy Sponsor: British Columbia Cancer Agency Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2020 Category: Research Source Type: clinical trials